Concepedia

Yumi Yokoyama

YY

Statistics

Publications

19

Citations

1.2K

H-Index

15

Active since

1996

Affiliations

University of Minnesota(Current)

Twin Cities Orthopedics

Tracon Pharmaceuticals (United States)

University of Minnesota Medical Center

University of California San Diego

Yumi Yokoyama is an author at University of Minnesota specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1996–2024

19

Publications

19

Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.

Yumi Yokoyama, Mohanraj Dhanabal, Arjan W. Griffioen et al. · PubMed · 2000 · 232 citations

, , +17

Effects of Angiogenesis Inhibitors on Vascular Network Formation by Human Endothelial and Melanoma Cells

Daisy W.J. van der Schaft, Richard E.B. Seftor, Elisabeth A. Seftor et al. · JNCI Journal of the National Cancer Institute · 2004 · 219 citations

, , +16

Targeting pancreatic cancer metabolic dependencies through glutamine antagonism

Joel Encarnación-Rosado, Albert S.W. Sohn, Douglas E. Biancur et al. · Nature Cancer · 2023 · 111 citations · Full text

, , +17

The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.

Ruud P.M. Dings, Yumi Yokoyama, Sundaram Ramakrishnan et al. · PubMed · 2003 · 107 citations

, , +16

Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor

Yumi Yokoyama, Erin D. Lew, Ruth Seelige et al. · Cancer Research · 2019 · 82 citations

, , +17

1–5 of 19